Results: 4

Development and validation of RP-HPLC method for simultaneous determination of lamivudine, stavudine, and zidovudine in perfusate samples: Application to the Single-Pass Intestinal Perfusion (SPIP) studies

A reversed-phase high performance liquid chromatography (RP-HPLC) method with ultraviolet detection was developed and validated for the simultaneous quantification of antiretroviral drugs lamivudine (3TC), stavudine (d4T), and zidovudine (AZT) in perfusate samples obtained from the Single-Pass Intestinal...

Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model

Braz. j. infect. dis; 22 (6), 2018
ABSTRACT Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, ...

Desenvolvimento e caracterização de nanopartículas de poli (n-butil cianoacrilato) contendo a associação lamivudina e zidovudina

A zidovudina (AZT), fármaco antirretroviral utilizado no tratamento da AIDS, apresenta biodisponibilidade oral em torno de 60% e seu uso prolongado pode ocasionar efeitos tóxicos e tolerância ao tratamento. A lamivudina (3TC), apesar de demonstrar menor citotoxicidade e menor resistência viral, é co...

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing

Braz. j. infect. dis; 20 (2), 2016